Bright Green Corporation
Bright Green Corporation
Your view on BGXXQ
Overview
What the company does, where it operates, and who runs it.
About Bright Green Corporation
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Lynn Stockwell
- Headquarters
- 401 East Las Olas Boulevard, Fort Lauderdale, FL, US
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Lynn Stockwell
- Headquarters
- 401 East Las Olas Boulevard, Fort Lauderdale, FL, US
Bright Green Corporation engages in the lawful cultivation, processing, and distribution of cannabis and related products. These offerings are made available for scientific research, medicinal applications, and international export, all while adhering strictly to federal and state regulations.
The enterprise was established in 2019 and maintains its principal operations in Fort Lauderdale, Florida.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Bright Green Corporation. Starting points for Bright Green Corporation: EPS -$0.07, beta -0.25 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Bright Green Corporation. Bright Green Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Bright Green Corporation. Trailing twelve-month EPS for Bright Green Corporation stands at -$0.07. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Sell
Analyst ratings
1 rating- Strong Buy0
- Buy0
- Hold0
- Sell1
- Strong Sell0
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Bright Green Corporation. Bright Green Corporation has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| AYRWFAyr Wellness Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $2.6M | ||
| AYURFAyurcann Holdings Corp. | Healthcare | Drug Manufacturers - Specialty & Generic | $389,408 | ||
| CLCFFChristina Lake Cannabis Corp. | Healthcare | Drug Manufacturers - Specialty & Generic | $6.2M | ||
| CNFHFCanaFarma Hemp Products Corp. | Healthcare | Drug Manufacturers - Specialty & Generic | $19,561 | ||
| IMTHInnovative MedTech Inc. | Healthcare | Medical - Instruments & Supplies | $89,758 | ||
| LOBEFLobe Sciences Ltd. | Healthcare | Biotechnology | $7.7M | ||
| OILFFNextleaf Solutions Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | $6.3M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| NSRXNasus Pharma Ltd. | Healthcare | AMEX | $19.7M | ||
| NUNZNunzia Pharmaceutical Company | Healthcare | OTC | $43,451 | ||
| OMHEOmni Health, Inc. | Healthcare | OTC | $29,291 | ||
| ORXOFOrexo AB (publ) | Healthcare | OTC | $111.5M | ||
| ORXOYOrexo AB (publ) | Healthcare | OTC | $102.7M | ||
| OVITOncoVista Innovative Therapies, Inc. | Healthcare | OTC | $2,356 | ||
| OXIHFOxford Investments Holdings Inc. | Healthcare | OTC | $71,958 | ||
| PAVSParanovus Entertainment Technology Ltd. | Healthcare | NASDAQ | $2.0M | ||
| PBHPrestige Consumer Healthcare Inc. | Healthcare | NYSE | $2.4B | ||
| PKBFFPeakBirch Commerce Inc. | Healthcare | OTC | $544.7M | ||
| PLWYPeoplesway.com Inc. | Healthcare | OTC | $1,508 | ||
| PNDHFPond Technologies Holdings Inc. | Healthcare | OTC | $684,738 | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Bright Green Corporation executives and directors. Shares of Bright Green Corporation have traded between $0.0000 and $0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Bright Green Corporation.